about

This book focusses on the debates concerning aspects of intellectual property law that bear on access to medicines in a set of developing countries. Specifically, the contributors look at measures that regulate the acquisition, recognition, and use of patent rights on pharmaceuticals and tradesecrets in data concerning them, along with the conditions under which these rights expire so as to permit the production of cheaper generic drugs. In addition, the book includes commentary from scholars in human rights, international institutions, and transnational activism. The case studies presented from 11 Latin American countries, have many commonalities in terms of economics, legal systems, and political histories, and yet they differ in the balance each has struck between proprietary interests and access concerns. The book documents this cross-country variation inlegal norms and practice, identifies the factors that have led to differences in result, and theorizes as to how differentials among these countries occur and why they endure within a common transnational regulatory regime. The work concludes by putting the results of the investigations into a global administrative law frame and offers suggestions on institutional mechanisms for considering the trade-offs between health and wealth.

About The Author

Rochelle C. Dreyfuss is the Pauline Newman Professor of Law at New York University School of Law and Director of the Engelberg Center on Innovation Law and Policy at NYU. She is a member of the American Law Institute and was a co-Reporter for its Project on Intellectual Property: Principles
Governing Jurisdiction, Choice of Law, and J...

Educational/Developmental Value:

Durability:

Hours of Play:

Thank you. Your review has been submitted and will appear here shortly.

Reviews

Extra Content

Table of Contents

Rochelle Dreyfuss and Cesar Rodriguez-Garavito: Introduction1. Tatiana Andia: Pharmaceutical Intellectual Property Rights Protection and Access to Medicines in Ecuador: State Sovereignty and Transnational Advocacy Networks2. Paola Bergallo and Agustina Ramon Michel: The Recursivity of Global Lawmaking in the Struggle for an Argentine Policy on Pharmaceutical Patents3. Angelina Snodgrass Godoy: CAFTA, Intellectual Property and the Right to Health in Central America4. Salvador Millaleo: Balancing Wealth and Health: The Case of Chile5. Cesar Rodriguez-Garavito: Constructing and Contesting the Global Intellectual Property Legal Field: The Struggle over Patent Rights and Access to Medicines in Colombia6. Monica Steffen Guise and Adelina de Oliveira Novaes: Balancing Health and Wealth: The Case of Patents and Access to Medicines in Brazil7. Laurence Helfer and Karen Alter: The Influence of the Andean Intellectual Property Regime on Access to Medicines in Latin America8. Smita Narula: The Rights-Based Approach to Intellectual Property And Access To Medicine: Parameters and Pitfalls9. Sean Flynn: Public Participation in US Special 301 Actions10. Amy Kapczynski: Going Local: Downshifting in the Era of TRIPS Implementation11. Molly Land: Applying Human Rights Law12. Ruth Okediji: The Missing Role of WIPO